Predicting ovarian cancer recurrence with exosomes
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial uses a blood test to look at tiny particles called exosomes to predict if ovarian cancer might come back. If you have been diagnosed with epithelial ovarian cancer in the last 8 weeks and haven't started treatment yet, this study could help you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman over 18 years old
- You have been diagnosed with epithelial ovarian cancer (any stage)
- You are able to care for yourself (ECOG score 0-2)
- Your diagnosis was made within the last 8 weeks
- You have not had any previous cancer treatment for ovarian cancer
- You have not had both ovaries removed before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to predict if ovarian cancer will come back after treatment. By looking at tiny particles called exosomes in your blood, researchers hope to create a score that can guide future care.
This trial tests a new blood-based test (OCS) that looks for tiny particles from tumor cells to watch for cancer returning after initial treatment. It is for women with ovarian cancer whose CA125 levels were normal before starting treatment.
This study uses a custom lab test on blood (and tumor tissue) to track ovarian cancer returning and to see how well treatment is working. It may help your care team monitor changes over time, especially after certain surgeries.
This study is testing a new blood test that may help detect ovarian cancer earlier. Researchers want to see if it can tell the difference between people with ovarian cancer and those without it.
This trial is testing a special blood test (called personalized ctDNA MRD) to see if it can give early warning about cancer returning after treatment. If you have cervical cancer that can be treated with surgery or chemoradiation, and you haven't had treatment yet, you may be eligible.
This study looks at tumor tissue from ovarian cancer patients to find “biomarkers,” or lab signals, that may predict how the disease behaves or how it might respond to treatment. You may be asked for a biopsy of the relapsed (coming back) tumor or to use an existing archived tumor sample.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.